Introduction

!
Upper urinary tract malignancies are relatively rare and account for only 5 % of urothelial cell carcinomas (UCCs) [1, 2] . Most upper urinary tract UCCs (75 %) are located in the renal pelvis and calyces, while the remaining 25 % are located in the ureter: 70 % in the distal ureter, 25 % in the mid-ureter and 5 % in the proximal ureter [3] . Multidetector computed tomographic urography (MDCTU) and magnetic resonance urography (MRU) are widely considered to be the best available modalities for the diagnosis and staging of urothelial carcinoma [4 -10] . The sensitivity (MDCTU 92.9 -100 %; MRU 62.9 -94.1 %) and specificity (MDCTU 93 -100 %; MRU 81 -100 %) of these methods are high but diagnosis is often based on the presence of indirect signs, such as wall thickening and hydroureteronephrosis, rather than on the actual recognition of the lesion. Ultrasound (US) is the first-line imaging modality in patients with hematuria [2] , as color Doppler US is useful in urological imaging and power Doppler US improves the sensitivity in the detection of slow blood flow [11] . The introduction of contrast-enhanced US (CEUS) has made it possible to detect and image blood flow in small vessels using microbubbles to assess regional microvascular perfusion in tissues such as the liver, kidney and myocardium [12] . The advantage of this method compared to MDCTU and MRU lies in the ability to provide real-time images of blood flow within the lesions. The main objective of this study was to assess the effectiveness of CEUS in the diagnosis of upper urinary tract neoplasms compared to MDCTU and MRU which are considered to be the gold standard. Secondary objectives were to assess the usefulness of CEUS in distinguishing high-grade tumors from low-grade ones on the basis of time-intensity curves and also to compare the tumor size measured with CEUS, MDCTU and MRU.
Materials and methods
!
Patient population
From January 2009 to September 2011, 18 patients, 10 males and 8 females (mean age: 74; range: 62 -85), were referred to diagnostic investigation with suspicion of upper urinary tract carcinoma due to persistent gross hematuria (n = 11) or microscopic hematuria (n = 7), positive or atypical urine cytology results but no abnormalities at cystoscopy ( • " Tab. 1). Written informed consent was obtained from all patients, and the procedures were in accordance with the ethical standards of the Committee on Human Experimentation of this institution.
Imaging techniques Investigational protocol
All patients underwent MDCTU or MRU to assess the presence of a neoplastic lesion. They subsequently underwent grayscale US, color Doppler (CDUS) and CEUS during the same session. The same radiologists performed US, color Doppler and CEUS; they were aware of the MDCTU and MRU findings.
All patients underwent surgery (nephroureterectomy with bladder cuff excision). The dimensions of the surgical specimen were recorded before it was submitted to histological examination which confirmed UCC in all cases.
MDCTU
Thirteen patients underwent MDCTU, which was performed on 64-MDCT scanners (Siemens, Erlangen, Germany) using a threephase protocol. 400 -500 ml of water were administered orally to the patients 20 minutes before the examination. Unenhanced CT scans of the abdomen and pelvis were obtained. Nephrographic phase images were then obtained 80 sec after bolus injection (2 ml/kg body weight) of iohexol (Omnipaque 300, GE Healthcare, USA) or iomeprolo (Iomeron 350, Bracco, Italy). Excretory phase images of the abdomen and pelvis were obtained 8 minutes after injection of the contrast agents. Unenhanced and nephrographic phase scans were reconstructed with sections with a thickness of 2 -5 mm. The excretory phase scan was reconstructed as sections with a thickness of 1.25 mm.
MRU
Five patients underwent MRU, which was performed on 1.5 T (Siemens) scanners. Multisequence MRI was carried out including T1-weighted and T2-weighted sequences (slice thickness: 6.6 -7.7 mm). Diffusion-weighted imaging (DWI) was carried out with single-shot spin-echo planar imaging sequences (slice thickness: 6 -7 mm). Spectral attenuated inversion recovery (SPAIR) fat suppression was performed under free-breathing acquisition. In the dynamic contrast-enhanced (DCE) MRI sequences, 24 slices were sequentially acquired 30, 80, and 180 sec after administration of meglumine gadopentetate (0.1 ml/kg body weight).
US and CDUS
All patients underwent grayscale US and CDUS. US examination was performed on Aplio (Toshiba, Tokyo, Japan), MyLab and MyLab-Twice (Esaote, Genoa, Italy) using a 3.5 -5 MHz multifrequency broadband convex transducer. Examination was performed when the urinary bladder was adequately full to visualize the possible presence of lesions in the ureteral-bladder junction. The location and size of the lesions detected during grayscale US were recorded. CDUS was performed using scanning parameters set for maximum sensitivity for slow flow while the power output was increased to maximum. Color gain was increased to the point just before the appearance of random noise. The pulse repetition frequency was set at the lowest possible level. The images were assigned the following scores: 0 = no color signal, 1 = low color signal, 2 = intense color signal.
CEUS
In the same session all patients underwent real-time continuous examination using a low mechanical index (range: 0.04 -0.1) after the administration of SonoVue (Bracco™). SonoVue is a blood pool US contrast agent comprising microbubbles. A total of 4.8 ml was administered in 2 intravenous bolus doses of 2.4 ml; the second dose was injected 15 minutes after the first and von hoch-und niedriggradigen Tumoren sowie die Abgrenzung des Tumors von den umgebenden Strukturen und eine exakte Größenbestimmung der Raumforderung ermöglicht. both were followed by 5 ml of a saline flush. The second injection was performed to evaluate the contralateral urinary tract. Still images of the entire examination were digitally recorded on magnetic optical disk. Recording was initiated at the start of the first contrast injection and at the start of the second injection. All time measurements started at these points, which were "time-0" in all recorded video clips. The images were analyzed off-site at consensus conferences to determine the size of the lesion, baseline and CDUS appearance as well as the signal intensity of the enhancement after SonoVue administration. The images were interpreted by the two radiologists who performed the examination. Both were skilled in urologic US and had more than 5 years of CEUS examination experience. Perfusion software was then used to estimate the perfusion pattern (Qontrast v 3.0, Bracco, Milan, Italy) [13] . This quantitative software analyzes the temporal sequence of the images. Time-intensity curves (TIC) were extracted from regions of interest in the lesion, and TIC quantitative analysis was performed. The following parameters were considered: wash-in time, time-to-peak (TTP), maximum signal intensity (SI) and wash-out time. The signal intensity was calculated for every pixel for every second, thus generating maps of perfusion parameters.
Statistical analysis
The paired T-test was performed to evaluate the statistical significance of the measurements obtained using the four imaging techniques. The measurements were compared to the actual length of the lesion measured on the surgical specimen.
Results
!
MRU and MDCTU identified upper urinary tract masses in all 18 patients, who subsequently underwent CEUS. Histological examination after surgery confirmed UCC in all patients. The lesions were located as follows: 9 (50 %) in the distal ureter; 4 (22.2 %) in the mid-ureter; 3 (16.6 %) in the proximal ureter; 2 (11.2 %) in the pelvicalyceal system. The mean dimension was 3.1 cm (range 1.2 -7.1 cm). In MDCTU and MRU, 18 lesions exhibited enhancement. In the urographic phase, the lesions did not exhibit direct enhance- 
Tab. 3 HG-UCC e LG-UCC in bladder and upper urinary tract (UUT).
HG-UCC
LG-UCC In the literature, the two most common sequences in MRU are T2-weighted hydrographic sequences without contrast agent and T1-spoiled gradient-recalled echo (GRE) sequences during the excretory phase after gadolinium administration [19, 20] with a sensitivity of 62.9 -76.5 % and a specificity of 89 -100 % [20, 21] . The use of DWI sequences substantially increases the sensitivity to up to 94.1 %, as compared to T1 and T2 sequences [9, 10] . In the present study, 18/18 lesions exhibited enhancement in MDCTU and MRU. During the urographic phase the lesions were diagnosed on the basis of other indicators such as thickening of the ureter wall or pelvicalyceal system as well as filling defects which were particularly evident in the 7 cases (38.8 %) affected by hydroureteronephrosis [17, 20, 22] . In grayscale US, UCC of the renal pelvis typically appears as a solid mass which is difficult to distinguish from the renal sinus, particularly in the absence of hydronephrosis [23 -25] . US has a limited role in the evaluation of UCC of the ureter as the ureter is rarely visualized in its entirety, even if dilated. When visualized, these tumors are typically intraluminal soft-tissue masses with proximal distention of the ureter. In the present study, grayscale US identified 15 lesions, while 3 were not identified. Two of the unidentified lesions were located in the mid-ureter and there was mild dilation of the ureter. The third undetected lesion was the smallest (1.2 cm) and was located in the upper pelvicalyceal system. The use of color Doppler did not significantly increase US sensitivity owing to the frequent absence of a vascular signal within the neoplastic lesion: 7 lesions out of 18 (38.8 %) were assigned a score of 0. In CEUS, 17 lesions out of 18 (94.4 %) exhibited enhancement offering direct visualization of the lesion. The lesion that was not detected in CEUS was located in the upper pelvicalyceal system of the kidney and was not identified in grayscale US ( • " Fig. 1 ). It probably went undetected because of the intense enhancement of the renal parenchyma which masked the enhancement of the lesion. TTP of the renal parenchyma occurred about 18 sec after the first injection of contrast agent and wash-out took more than 5 min thereby completely masking the lesion. In the present patient population, CEUS identified another lesion located in the calyceal cavity as it was larger and caused swelling of the renal pelvis. This may indicate a greater sensitivity of CEUS in masses located in the ureter (16 out of 16 lesions were identified; sensitivity 100 %) than in smaller lesions located in the calyceal system (1 out of 2 lesions was identified; sensitivity 50 %). The overall sensitivity of CEUS was 94.4 %. Because of the lack of false-positive and true-negative patients, the sensitivity was the only statistical datum that could be extrapolated about CEUS in the detection of upper urinary tract UCCs. MDCTU and MRU overestimated tumor size by 15 -20 %. This phenomenon is probably due to the fact that it is difficult to differentiate between the lesion and the ureteral walls or the calyceal walls because of concurrent enhancement of the lesion and the surrounding wall with no neoplasm [26] . Grayscale US also overestimated tumor size by about 25 %. In most cases this phenomenon is linked to the presence of intraluminal echoes due to artifacts, cellular debris and/or blood clots. CEUS yielded tumor sizes close to the actual dimensions of the surgical specimens as amplitude subtraction permitted the suppression of intraluminal echoes caused by artifacts ( • " Fig. 2, 3) . Agreement between the actual tumor size of the surgical specimen and the size measured in CEUS shows that areas exhibiting enhancement in CEUS are actually neoplastic lesions. The fact that CEUS showed a vascular signal from the lesion in an elevated percentage of cases, i. e., higher than CDUS and close to MDCTU/MRU (CEUS 94 %; CDUS 61 %; MDCTU/MRU 100 % of cases), may be attributed to the ability of the US blood pool contrast agent to provide real-time depiction of the lesion vascularity. The clips obtained in CEUS were used for the construction of TICs for the comparison between enhancement patterns of highgrade and low-grade UCCs. This semi-quantitative analysis was compared to data obtained from studies of the bladder [27, 28] . Semi-quantitative analysis of high-grade and low-grade UCCs of the urinary tract yielded results similar to those related to bladder cancer. The only contrasting data with regard to the signal intensity of high-grade UCCs was a case in which the lesion was located in the mid-ureter in close proximity to the iliac artery. In this case the SI was lower than the SI observed in the other cases. The close proximity of the iliac artery, where there were high concentrations of contrast agent, may have altered the SI measurement of the neoplastic lesion ( • " Fig. 4) . The limitations of this study are related to the patient population. The first limitation is the low number of patients which is partly due to the relative rarity of upper urinary tract UCCs. Only 5 -10 % of UCCs affect the upper urinary tract, while the remaining 90 -95 % are located in the bladder [2] . The second limitation is related to the selection criteria, as all the recruited patients already had a MDCTU and/or MRU report positive for the presence of an upper urinary tract lesion and urinary cytology positive for malignant cells. However, this was needed to assess the reliability of CEUS in the detection of upper urinary tract UCCs.
Conclusions
!
The results of this study show that CEUS is a useful tool for evaluating upper urinary tract tumors as nearly all lesions were detected. CEUS allows a semi-quantitative analysis for differentiating the degree of malignancy, an accurate measurement of the mass by image subtraction, thus avoiding artifacts, and distinction of the tumor from adjacent structures based on enhancement timing. CEUS may become a first-line examination in the diagnosis of upper urinary tract masses because of the short execution time and relatively low cost and thereby become an alternative to MRU and MDCTU in patients who are allergic to contrast agents or are affected by renal failure. However, further studies involving larger patient populations are mandatory to confirm these encouraging preliminary results.
